“mpm-capital” Archives

in
Entry Author Date Location
Oncorus Lands $57,000,000 Series A Financing Round 07/20/16 Boston
Oncorus Bags $57M, Touts Next-Gen Take on Cancer-Fighting Viruses 07/19/16 Boston
Blade Therapeutics Garners $45,000,000 Series B Funding 06/20/16 San Francisco
Tizona Therapeutics Obtains $43,000,000 Series B Funding 03/08/16 San Francisco
Syndax Cuts Price But Bags $53M in Second IPO Try 03/02/16 Boston
Seeking A Fresh Start in Gene Therapy, Avalanche Merges With Annapurna 02/01/16 San Francisco
Iconic Therapeutics Secures $40,000,000 Series C Financing Round 01/11/16 San Francisco
True North Therapeutics Secures $40,000,000 Series C Financing Round 12/03/15 San Francisco
23andMe Garners $115,000,000 Series E Financing 10/14/15 San Francisco
New CEO and $80M Later, Syndax Looks Prepped for Second IPO Try 08/24/15 Boston
Syndax Pharmaceuticals Garners $80,000,000 New Financing 08/24/15 Boston
East Coast Biotech Roundup: Vertex, Moderna, Sage, ASCO & More 05/15/15 Boston
East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More 04/24/15 Boston
East Coast Biotech Roundup: Hemophilia, Levin, Vertex, Semma & More 03/27/15 Boston
Semma Secures $44M to Develop Diabetes Stem Cell Therapy 03/24/15 Boston
Clinical Ink, CentrosHealth Merge in Paperless Drug Trials Push 03/19/15 Raleigh Durham
Vascular Pharmaceuticals Lands $9M For Diabetes Drug Trials 03/03/15 Raleigh Durham
Well-Traveled Rhodes Leaves Epizyme For Atlas Venture Partnership 09/29/14 Boston
Sold For Parts, Accelerator Grad Allozyne Reaches End of the Line 09/18/14 Seattle
FDA OKs Astute Medical’s First Diagnostic for Acute Kidney Injury 09/08/14 San Diego
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
East Coast Biotech Roundup: Biogen, Civitas, Rhythm, Alkermes, & More 08/29/14 Boston
To Take On New York, Accelerator Makes Big Changes 08/14/14 New York
With $22M, True North Points Toward Rare-Disease Clinical Trials 06/17/14 San Francisco
Radius Health Recharges IPO After Two Week Hiatus 05/21/14 Boston
With Novartis Deal Dead, Proteon Embarks on Plan B With $45M Round 05/16/14 Boston
East Coast Biotech Roundup: Mergers, Rhythm, Regeneron, & More 05/09/14 Boston
Rhythm Eyes Pivotal Study as GI Drug for Diabetics Hits Phase 2 Mark 05/06/14 Boston
Seeking Tau: BMS Buys iPierian and Brain-Disease Program for $175M 04/29/14 San Francisco
Syndax Plots $69M IPO For Cancer Drug’s Stretch Run 03/27/14 Boston
Page 1 of 8 next page »